Amplify Weight Loss Drug & Treatment ETF Rating $23.23 +0.14 (+0.61%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.79Holdings in THNR have an aggregate rating of Moderate Buy based on 193 analyst ratings issued in the past year covering 15 companies (69.9% of the portfolio).THNR Aggregate Price Target$23.23High Prediction$23.23Average Prediction$23.23Low Prediction$23.23Holdings in THNR have an aggregate price target of $23.23 and a range of $23.23 to $23.23 covering 15 companies (69.9% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 15 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.24%LLYEli Lilly and Company$874.12+0.1%4.8441 of 5 stars2.85$1,007.94 15.3%20Positive News12.44%NVONovo Nordisk A/S$88.07+5.2%4.4878 of 5 stars2.88$145.25 64.9%8Gap Up5.63%TMOThermo Fisher Scientific$532.55-1.0%4.7368 of 5 stars2.82$658.00 23.6%22Dividend IncreaseAnalyst RevisionPositive News5.61%AMGNAmgen$303.01+1.7%4.4673 of 5 stars2.46$314.09 3.7%24Insider TradePositive News5.58%AZNAstraZeneca$74.20-0.5%2.6889 of 5 stars3.10$89.75 21.0%10Options Volume5.26%PFEPfizer$26.32+1.6%4.9993 of 5 stars2.50$31.92 21.3%16Options VolumePositive News4.49%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume4.39%WSTWest Pharmaceutical Services$210.72+3.5%4.9557 of 5 stars2.83$344.00 63.2%6Dividend AnnouncementAnalyst Downgrade3.63%TEVATeva Pharmaceutical Industries$16.75-1.5%2.8959 of 5 stars2.86$23.57 40.8%72.20%GPCRStructure Therapeutics$23.70+1.3%2.5058 of 5 stars3.00$81.29 243.1%81.54%VKTXViking Therapeutics$34.07+7.7%4.3881 of 5 stars3.00$97.29 185.5%15High Trading Volume1.32%HIMSHims & Hers Health$49.10-26.1%2.6445 of 5 stars2.29$28.53 -41.9%17Analyst DowngradeInsider TradeNews CoverageGap DownHigh Trading Volume0.23%OPKOPKO Health$1.68+0.6%4.0141 of 5 stars3.00$2.75 63.7%30.22%ALTAltimmune$6.43-3.0%2.6149 of 5 stars3.00$20.83 224.0%8Short Interest ↓News Coverage0.13%TERNTerns Pharmaceuticals$4.01-2.9%4.4005 of 5 stars2.80$18.30 356.4%5 This page (NYSEARCA:THNR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
